Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2023-10-11 | 2023-08-15 |
Drug Identification Number | 02486822 | 02486822 |
Brand name | VPI-BENZTROPINE | VPI-BENZTROPINE |
Common or Proper name | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE |
Company Name | PHEBRA PTY LTD | PHEBRA PTY LTD |
Ingredients | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE |
Strength(s) | 2MG | 2MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | Vials of 2 ml, boxes of 10 | Vials of 2 ml, boxes of 10 |
ATC code | N04AC | N04AC |
ATC description | ANTICHOLINERGIC AGENTS | ANTICHOLINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2023-03-30 | 2023-03-30 |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | The estimated end date is unknown due to an ongoing administrative change (DIN transfer in progress). | |
Health Canada comments |